368 related articles for article (PubMed ID: 18187417)
41. BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases.
Geyer R; Wee S; Anderson S; Yates J; Wolf DA
Mol Cell; 2003 Sep; 12(3):783-90. PubMed ID: 14527422
[TBL] [Abstract][Full Text] [Related]
42. ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex.
Heuzé ML; Guibal FC; Banks CA; Conaway JW; Conaway RC; Cayre YE; Benecke A; Lutz PG
J Biol Chem; 2005 Feb; 280(7):5468-74. PubMed ID: 15590664
[TBL] [Abstract][Full Text] [Related]
43. No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer.
Huang KT; Dobrovic A; Fox SB
Breast Cancer Res Treat; 2010 Dec; 124(3):853-6. PubMed ID: 20680678
[TBL] [Abstract][Full Text] [Related]
44. Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics.
Shafique S; Ali W; Kanwal S; Rashid S
Int J Biol Macromol; 2018 Jan; 106():532-543. PubMed ID: 28802844
[TBL] [Abstract][Full Text] [Related]
45. Atlas on substrate recognition subunits of CRL2 E3 ligases.
Wang S; Xia W; Qiu M; Wang X; Jiang F; Yin R; Xu L
Oncotarget; 2016 Jul; 7(29):46707-46716. PubMed ID: 27107416
[TBL] [Abstract][Full Text] [Related]
46. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C.
Okuda H; Saitoh K; Hirai S; Iwai K; Takaki Y; Baba M; Minato N; Ohno S; Shuin T
J Biol Chem; 2001 Nov; 276(47):43611-7. PubMed ID: 11574546
[TBL] [Abstract][Full Text] [Related]
47. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.
Pause A; Lee S; Worrell RA; Chen DY; Burgess WH; Linehan WM; Klausner RD
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2156-61. PubMed ID: 9122164
[TBL] [Abstract][Full Text] [Related]
48. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
49. Structure and dynamics of the ASB9 CUL-RING E3 Ligase.
Lumpkin RJ; Baker RW; Leschziner AE; Komives EA
Nat Commun; 2020 Jun; 11(1):2866. PubMed ID: 32513959
[TBL] [Abstract][Full Text] [Related]
50. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.
Schoenfeld AR; Davidowitz EJ; Burk RD
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8507-12. PubMed ID: 10900011
[TBL] [Abstract][Full Text] [Related]
51. Imaging-based assays for investigating functions of the RNA polymerase II elongation factor Elongin and the Elongin ubiquitin ligase.
Weems JC; Unruh JR; Slaughter BD; Conaway RC; Conaway JW
Methods; 2019 Apr; 159-160():157-164. PubMed ID: 30794906
[TBL] [Abstract][Full Text] [Related]
52. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.
Bergeron JR; Huthoff H; Veselkov DA; Beavil RL; Simpson PJ; Matthews SJ; Malim MH; Sanderson MR
PLoS Pathog; 2010 Jun; 6(6):e1000925. PubMed ID: 20532212
[TBL] [Abstract][Full Text] [Related]
53. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
[TBL] [Abstract][Full Text] [Related]
54. Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5.
Baxter SS; Carlson LA; Mayer AM; Hall ML; Fay MJ
In Vitro Cell Dev Biol Anim; 2009; 45(5-6):264-74. PubMed ID: 19118439
[TBL] [Abstract][Full Text] [Related]
55. DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase.
Heir P; Sufan RI; Greer SN; Poon BP; Lee JE; Ohh M
Mol Cell Biol; 2013 Apr; 33(8):1621-31. PubMed ID: 23401859
[TBL] [Abstract][Full Text] [Related]
56. Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein.
Takagi Y; Pause A; Conaway RC; Conaway JW
J Biol Chem; 1997 Oct; 272(43):27444-9. PubMed ID: 9341197
[TBL] [Abstract][Full Text] [Related]
57. Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53.
Luo K; Ehrlich E; Xiao Z; Zhang W; Ketner G; Yu XF
FASEB J; 2007 Jun; 21(8):1742-50. PubMed ID: 17351129
[TBL] [Abstract][Full Text] [Related]
58. C. elegans RBX-2-CUL-5- and RBX-1-CUL-2-based complexes are redundant for oogenesis and activation of the MAP kinase MPK-1.
Sasagawa Y; Sato S; Ogura T; Higashitani A
FEBS Lett; 2007 Jan; 581(1):145-50. PubMed ID: 17184777
[TBL] [Abstract][Full Text] [Related]
59. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.
Ohh M; Takagi Y; Aso T; Stebbins CE; Pavletich NP; Zbar B; Conaway RC; Conaway JW; Kaelin WG
J Clin Invest; 1999 Dec; 104(11):1583-91. PubMed ID: 10587522
[TBL] [Abstract][Full Text] [Related]
60. BC-box protein domain-related mechanism for VHL protein degradation.
Pozzebon ME; Varadaraj A; Mattoscio D; Jaffray EG; Miccolo C; Galimberti V; Tommasino M; Hay RT; Chiocca S
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18168-73. PubMed ID: 24145437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
